NIPT(新型出生前診断)の中国市場

【英語タイトル】Non–Invasive Prenatal Testing(NIPT) Market Outlook 2024: China Opportunity and Demand Analysis, Market Forecast 2017–2024

DPI Researchが出版した調査資料(DPI803003)・商品コード:DPI803003
・発行会社(調査会社):DPI Research
・発行日:2017年12月4日
・ページ数:55
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール
・調査対象地域:中国
・産業分野:医療
◆販売価格オプション(消費税別)
Single UserUSD800 ⇒換算¥91,200見積依頼/購入/質問フォーム
Enterprisewide Price (Global Site License)USD1,300 ⇒換算¥148,200見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
【レポートの概要】

China Potential Non–Invasive Prenatal Testing (NIPT) market is likely to reach more than US$ 1.7 Billion by 2024.
Long–term Growth Projection and Development:

• It is predicted that China Actual NIPT test volume will increase to 1.6 Million by 2024
• More than 3,00,000 NIFTY tests done in 2016
• Berry Genomics completes US$ 648 Million reverse merger in Shenzhen
• Two–Child policy is likely to boost China NIPT market

Growth in China NIPT market can be attributed to factors such as high incidence rate of babies born with Down syndrome, no risk of miscarriage with NIPT and shifting trend towards child bearing at advanced maternal age (35 years or older). High test cost, strict regulatory requirements and ethical hurdles is restraining the growth of China NIPT market. Due to expanding patient access to NIPT test, the China NIPT test market is poised to have a positive outlook in the year ahead.

The research report titled “Non–Invasive Prenatal Testing(NIPT) Market Outlook 2024: China Opportunity and Demand Analysis, Market Forecast 2017–2024” examines the market dynamics, competitive landscape and discusses major trends. The study describes an in–depth analysis of the China actual and potential NIPT market.

The report contains a granular analysis of the market segmentation, reveal facts on the market size, volume and revenues; and provides forecasts through 2024. It also includes a snapshot of the NIPT implementation in the low and middle-income countries. The report also explores detailed description of growth drivers and inhibitors of the China NIPT Market.

The report concludes with the profiles of major players in the China NIPT Market. The key market players are evaluated on various parameters such as company introduction, NIPT test portfolio, NIPT test analysis with volume and market revenue and latest development/updates of the NIPT Market in China.

Key Topics Covered in the Report

• 2013 – 2024: China Potential NIPT Test Market Size & Analysis (Volume and Value)
• 2013 – 2024: China Actual NIPT Test Market Size & Analysis (Volume and Value)
• NIPT Test Implementation in Low & Middle–Income Countries
• Key Companies Analysis
• Key Drivers and Inhibitors of the China NIPT Test Market

Key Companies Covered in the Report are as follows:

• Berry Genomics
• BGI Diagnosis Co., Ltd
• Basetra

【レポートの目次】

1. Executive Summary

2. Market Size & Analysis: China Potential NIPT Test (Volume and Value)
2.1 Potential NIPT Test Volume (2013 – 2024)
2.2 Potential NIPT Test Market (2013 – 2024)

3. Market Size & Analysis: China Actual NIPT Test (Volume and Value)
3.1 Actual NIPT Test Volume (2013 – 2024)
3.2 Actual NIPT Test Market (2013 – 2024)

4. Key Drivers and Inhibitors of the China NIPT Market
4.1 Market Drivers
4.2 Market Inhibitors

5. Non–Invasive Prenatal Testing (NIPT) Implementation – Low & Middle–Income Countries

6. China NIPT Key Players: Company Profiles
6.1 BGI Diagnosis Co., Ltd
6.1.1 Company Introduction
6.1.2 Product Portfolio
6.1.2.1 NIFTY Test
6.1.3 NIPT Test Analysis (Volume and Value)
6.1.3.1 Overall NIPT Test Volume & Forecast
6.1.3.2 Overall NIPT Test Market Revenue & Forecast
6.1.4 Latest Development/Updates
6.2 Berry Genomics
6.2.1 Company Introduction
6.2.2 Product Portfolio
6.2.2.1 Bambni Test
6.2.3 NIPT Test Analysis (Volume and Value)
6.2.3.1 Overall NIPT Test Volume & Forecast
6.2.3.2 Overall NIPT Test Market Revenue & Forecast
6.2.4 Latest Development/Updates
6.3 Basetra
6.3.1 Company Introduction
6.3.2 Product Portfolio
6.3.2.1 Babyguard



Figure 2–1: China – Potential NIPT Test Volume (Million),2013 – 2016
Figure 2–2: China – Forecast for Potential NIPT Test Volume (Million),2017 – 2024
Figure 2–3: China – Potential NIPT Test Market (Million US$),2013 – 2016
Figure 2–4: China – Forecast for Potential NIPT Test Market (Million US$),2017 – 2024
Figure 3–1: China – Actual NIPT Test Volume (Number),2013 – 2016
Figure 3–2: China – Forecast for Actual NIPT Test Volume (Number),2017 – 2024
Figure 3–3: China – Actual NIPT Test Market (Million US$),2013 – 2016
Figure 3–4: China – Forecast for Actual NIPT Test Market (Million US$),2017 – 2024
Figure 6–1: Overall NIFTY Test Volume (Number), 2012 – 2016
Figure 6–2: Overall – Forecast for NIFTY Test Volume (Number), 2017 – 2024
Figure 6–3: Overall – NIFTY Test Market Revenue (Million US$), 2012 – 2016
Figure 6–4: Overall – Forecast for NIFTY Test Market Revenue (Million US$), 2017 – 2024
Figure 6–5: Overall – Bambini Test Volume (Number), 2012 – 2016
Figure 6–6: Overall – Forecast for Bambini Test Volume (Number), 2017 – 2024
Figure 6–7: Overall – Bambini Test Market Revenue (Million US$), 2012 – 2016
Figure 6–8: Overall – Forecast for Bambini Test Market Revenue (Million US$), 2017 – 2024


★調査レポート[NIPT(新型出生前診断)の中国市場] (コード:DPI803003)販売に関する免責事項を必ずご確認ください。
★調査レポート[NIPT(新型出生前診断)の中国市場]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆